JP2025512469A5 - - Google Patents

Info

Publication number
JP2025512469A5
JP2025512469A5 JP2024560676A JP2024560676A JP2025512469A5 JP 2025512469 A5 JP2025512469 A5 JP 2025512469A5 JP 2024560676 A JP2024560676 A JP 2024560676A JP 2024560676 A JP2024560676 A JP 2024560676A JP 2025512469 A5 JP2025512469 A5 JP 2025512469A5
Authority
JP
Japan
Application number
JP2024560676A
Other languages
Japanese (ja)
Other versions
JPWO2023201324A5 (https=
JP2025512469A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/065764 external-priority patent/WO2023201324A1/en
Publication of JP2025512469A publication Critical patent/JP2025512469A/ja
Publication of JPWO2023201324A5 publication Critical patent/JPWO2023201324A5/ja
Publication of JP2025512469A5 publication Critical patent/JP2025512469A5/ja
Pending legal-status Critical Current

Links

JP2024560676A 2022-04-15 2023-04-14 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用 Pending JP2025512469A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263331716P 2022-04-15 2022-04-15
US63/331,716 2022-04-15
PCT/US2023/065764 WO2023201324A1 (en) 2022-04-15 2023-04-14 Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Publications (3)

Publication Number Publication Date
JP2025512469A JP2025512469A (ja) 2025-04-17
JPWO2023201324A5 JPWO2023201324A5 (https=) 2026-02-02
JP2025512469A5 true JP2025512469A5 (https=) 2026-02-02

Family

ID=88330384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560676A Pending JP2025512469A (ja) 2022-04-15 2023-04-14 筋緊張性ジストロフィーを処置するための筋標的化複合体およびその使用

Country Status (10)

Country Link
US (1) US20250249116A1 (https=)
EP (1) EP4508091A1 (https=)
JP (1) JP2025512469A (https=)
KR (1) KR20250004769A (https=)
CN (1) CN119256008A (https=)
AU (1) AU2023253710A1 (https=)
CA (1) CA3248961A1 (https=)
IL (1) IL315944A (https=)
MX (1) MX2024012737A (https=)
WO (1) WO2023201324A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11168141B2 (en) 2018-08-02 2021-11-09 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating dystrophinopathies
US11911484B2 (en) 2018-08-02 2024-02-27 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
EP3829595A4 (en) 2018-08-02 2022-08-24 Dyne Therapeutics, Inc. MUSCLE-DIRECTED COMPLEXES AND USES THEREOF IN THE TREATMENT OF DYSTROPHINOPATHIES
US12018087B2 (en) 2018-08-02 2024-06-25 Dyne Therapeutics, Inc. Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
US12370264B1 (en) 2018-08-02 2025-07-29 Dyne Therapeutics, Inc. Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
US20220193250A1 (en) 2018-08-02 2022-06-23 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
US12097263B2 (en) 2018-08-02 2024-09-24 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy
US11771776B2 (en) 2021-07-09 2023-10-03 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating dystrophinopathies
IL309936A (en) 2021-07-09 2024-03-01 Dyne Therapeutics Inc Muscle targeting complexes and formulations for the treatment of dystrophinopathy
US11969475B2 (en) 2021-07-09 2024-04-30 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
US20250339553A1 (en) 2022-04-15 2025-11-06 Dyne Therapeutics, Inc. Muscle targeting complexes and formulations for treating myotonic dystrophy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012007896A1 (en) * 2010-07-12 2012-01-19 Covx Technologies Ireland, Ltd. Multifunctional antibody conjugates
AU2021318851A1 (en) * 2020-07-23 2023-03-16 Dyne Therapeutics, Inc. Muscle targeting complexes and uses thereof for treating myotonic dystrophy

Similar Documents

Publication Publication Date Title
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BY13149U (https=)
BY13157U (https=)
CN307049640S (https=)
BY13137U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
CN307049002S (https=)